BlueWhale Bio is dedicated to accelerating the growth and adoption of cell-based therapies. With the demand for cell therapy products surpassing supply, BlueWhale Bio aims to address critical shortcomings in the current treatment paradigm. The company is developing a portfolio of groundbreaking products that bring the full benefits of cell therapy to more patients faster and at lower costs. For the Synecta™ platform, we focus on activation and expansion, as this early stage in the cell therapy manufacturing process defines which cells can be effectively processed and sets the stage for the efficiency and simplicity of all downstream steps.